Related Experiment Videos

Expression of apolipoprotein E mRNA in rat microglia

M Nakai1, T Kawamata, T Taniguchi

  • 1Hyogo Institute for Aging Brain and Cognitive Disorders, Himeji, Japan.

Neuroscience Letters
|June 14, 1996
PubMed

Insights

Microglia, a type of brain cell, can produce apolipoprotein E (apoE), a known risk factor for Alzheimer disease (AD). This finding suggests microglia may contribute to AD pathogenesis.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Apolipoprotein E (apoE) is a key genetic risk factor for Alzheimer disease (AD).
  • ApoE is traditionally thought to be synthesized by astrocytes and utilized by microglia and neurons.
  • The potential for microglia to synthesize apoE in the brain has not been established.

Purpose of the Study:

  • To investigate whether microglia can synthesize apolipoprotein E (apoE) in the brain.
  • To determine the role of microglia in apoE production within the central nervous system.

Main Methods:

  • Primary rat microglia cultures were established.
  • Reverse transcriptase-polymerase chain reaction (RT-PCR) was employed to detect apoE mRNA expression.
  • RT-in situ-PCR was utilized for precise localization of apoE mRNA within microglia.

Main Results:

  • Cultured rat microglia demonstrated the expression of apoE mRNA.
  • RT-in situ-PCR confirmed the presence of apoE mRNA within microglia cells.
  • These findings indicate that microglia are capable of biosynthesizing apoE.

Conclusions:

  • Microglia are identified as a potential source of apolipoprotein E (apoE) in the brain.
  • The apoE synthesized by microglia may play a role in the pathogenesis of Alzheimer disease (AD).
  • This research opens new avenues for understanding AD mechanisms and potential therapeutic targets.

Related Concept Videos